Why This Seattle Biotech Could be an M&A Target Post author:Sam Post published:January 18, 2018 Post category:BioPharma Immune Design is a clinical-stage immunotherapy company. Source: BioSpace You Might Also Like Charles River Laboratories: Business Is Booming With 500 Positions Open May 4, 2017 31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant February 2, 2017 <b>UBM Medica</b>'s <b>Oncology And Society For Integrative Oncology (Sio)</b> Announce Partnership July 30, 2017
<b>UBM Medica</b>'s <b>Oncology And Society For Integrative Oncology (Sio)</b> Announce Partnership July 30, 2017
